UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer

The American journal of pathology, 1993-02, Vol.142 (2), p.359-365

1993

Volltextzugriff (PDF)

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

The American journal of pathology, 1991-05, Vol.138 (5), p.1059-1067

1991

Volltextzugriff (PDF)

Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases

British journal of dermatology (1951), 2000-05, Vol.142 (5), p.913-923

2000

Volltextzugriff (PDF)

Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization

Cancer research (Chicago, Ill.), 1992-03, Vol.52 (5), p.1336-1341

1992

Volltextzugriff (PDF)

Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma

Cancer research (Chicago, Ill.), 1993-04, Vol.53 (8), p.1911-1915

1993

Volltextzugriff (PDF)

15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau

British journal of haematology, 2016-11, Vol.175 (3), p.410-418

2016

Volltextzugriff (PDF)

FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival

Leukemia, 2007-12, Vol.21 (12), p.2512-2518

2007

Volltextzugriff (PDF)

Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma

Histopathology, 2008-09, Vol.53 (3), p.267-277

2008

Volltextzugriff (PDF)

Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer

Histopathology, 1994-02, Vol.24 (2), p.131-138

1994

Volltextzugriff (PDF)

Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans

The American journal of pathology, 1991-01, Vol.138 (1), p.111-117

1991

Volltextzugriff (PDF)

Mantle cell lymphoma in the orbital and adnexal region

British journal of ophthalmology, 2009-08, Vol.93 (8), p.1047-1051

2009

Volltextzugriff (PDF)

Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

Histopathology, 2002-07, Vol.41 (1), p.1-29

2002

Volltextzugriff (PDF)

Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome

Leukemia, 2008-12, Vol.22 (12), p.2230-2239

2008

Volltextzugriff (PDF)

Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia

Leukemia, 2007-12, Vol.21 (12), p.2406-2410

2007

Volltextzugriff (PDF)

Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma

Haematologica (Roma), 2013-12, Vol.98 (12), p.1912-1920

2013

Volltextzugriff (PDF)

Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue

American journal of clinical pathology, 1994-12, Vol.102 (6), p.835-841

1994

Volltextzugriff (PDF)

EORTC classification for primary cutaneous lymphomas : A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer

Blood, 1997-07, Vol.90 (1), p.354-371

1997

Volltextzugriff (PDF)

COX-2-dependent PGE acts as a growth factor in mycosis fungoides (MF)

Leukemia, 2010-06, Vol.24 (6), p.1179-1185

2010

Volltextzugriff (PDF)

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

Journal of clinical oncology, 2012-09, Vol.30 (25), p.3093-3099

2012

Volltextzugriff (PDF)

Urokinase- and Tissue-Type Plasminogen Activators in Keratinocytes During Wound Reepithelialization In Vivo

Journal of investigative dermatology, 1988-06, Vol.90 (6), p.790-795

1988

Volltextzugriff (PDF)

YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS

Hematological oncology, 2019-06, Vol.37 (S2), p.132-132

2019

Volltextzugriff (PDF)

COX-2-dependent PGE2 acts as a growth factor in mycosis fungoides (MF)

Leukemia, 2010-06, Vol.24 (6), p.1179-1185

2010

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(199)

Publikationsform

Sprache

Englisch
(232)
Dänisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(169)
Life Sciences & Biomedicine
(154)
Science & Technology
(154)
Biological And Medical Sciences
(128)
Medical Sciences
(127)
Hematologic And Hematopoietic Diseases
(79)
Male
(79)
Female
(78)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(75)
Middle Aged
(72)
Adult
(64)
Aged
(63)
Dermatology
(49)
Hematology
(49)
Pathology
(47)
Medicin Och Hälsovetenskap
(31)
Oncology
(30)
Immunoenzyme Techniques
(28)
Antibodies, Monoclonal
(27)
Skin Neoplasms - Pathology
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases

Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization

Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma

15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau

FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival

Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma

Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer

Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans

Mantle cell lymphoma in the orbital and adnexal region

Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome

Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma

Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

EORTC classification for primary cutaneous lymphomas : A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer

COX-2-dependent PGE acts as a growth factor in mycosis fungoides (MF)

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

Urokinase- and Tissue-Type Plasminogen Activators in Keratinocytes During Wound Reepithelialization In Vivo

YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS

COX-2-dependent PGE2 acts as a growth factor in mycosis fungoides (MF)

Suchergebnisse filtern